Jane Street
IBRX icon

Jane Street’s ImmunityBio IBRX Stock Holding History

Jane Street’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Sell
72,397
-631,835
-90% -$4.78M ﹤0.01% 7478
2026
Q1 		$5.4M Sell
704,232
-13,519,992
-95% -$92.6M ﹤0.01% 3393
2025
Q4 		$28.2M Buy
14,224,224
+1,388,645
+11% +$3.15M ﹤0.01% 1318
2025
Q3 		$31.6M Buy
12,835,579
+5,117,314
+66% +$13.2M ﹤0.01% 1254
2025
Q2 		$20.4M Buy
7,718,265
+7,588,902
+5,866% +$20.4M ﹤0.01% 1439
2025
Q1 		$389K Sell
129,363
-122,712
-49% -$372K ﹤0.01% 7339
2024
Q4 		$645K Buy
252,075
+156,466
+164% +$652K ﹤0.01% 6230
2024
Q3 		$356K Sell
95,609
-1,620,450
-94% -$7.5M ﹤0.01% 7755
2024
Q2 		$10.8M Buy
1,716,059
+1,407,921
+457% +$9.28M ﹤0.01% 1958
2024
Q1 		$1.65M Sell
308,138
-513,505
-62% -$2.33M ﹤0.01% 4473
2023
Q4 		$4.12M Buy
+821,643
New +$2.58M ﹤0.01% 3141
2023
Q3 		– Sell
-146,732
Closed -$295K – 8951
2023
Q2 		$408K Sell
146,732
-78,024
-35% -$221K ﹤0.01% 6635
2023
Q1 		$409K Buy
224,756
+177,896
+380% +$553K ﹤0.01% 6672
2022
Q4 		$238K Buy
46,860
+27,986
+148% +$154K ﹤0.01% 7400
2022
Q3 		$94K Sell
18,874
-23,731
-56% -$108K ﹤0.01% 8674
2022
Q2 		$159K Sell
42,605
-107,001
-72% -$430K ﹤0.01% 8372
2022
Q1 		$840K Buy
149,606
+122,403
+450% +$751K ﹤0.01% 6483
2021
Q4 		$165K Buy
27,203
+15,145
+126% +$114K ﹤0.01% 8952
2021
Q3 		$118K Sell
12,058
-17,990
-60% -$198K ﹤0.01% 9203
2021
Q2 		$429K Sell
30,048
-12,528
-29% -$207K ﹤0.01% 7524
2021
Q1 		$1.01M Sell
42,576
-30,265
-42% -$785K ﹤0.01% 5434
2020
Q4 		$971K Buy
72,841
+35,041
+93% +$337K ﹤0.01% 4695
2020
Q3 		$262K Sell
37,800
-26,853
-42% -$268K ﹤0.01% 6072
2020
Q2 		$794K Buy
+64,653
New +$365K ﹤0.01% 4411
2019
Q3 		– Sell
-89,914
Closed -$92K – 5379
2019
Q2 		$92K Buy
+89,914
New +$104K ﹤0.01% 4873

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street's IBRX Position: Q2 2026 in Review

Jane Street reduced its ImmunityBio (IBRX) stake by 90% in Q2 2026, selling an estimated $4.78M and leaving 72,397 shares worth $634K. The position accounts for ﹤0.01% of the portfolio, ranked #7478.

Jane Street first reported a position in IBRX in Q2 2019 and has held it in 25 quarters since. The position peaked at $31.6M in Q3 2025. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Jane Street held 72,397 shares of ImmunityBio worth $634K as of Q2 2026.
  • Jane Street sold 631,835 ImmunityBio shares in Q2 2026, an estimated $4.78M.
  • ImmunityBio made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7478 holding.
  • Jane Street first reported a position in ImmunityBio in Q2 2019 and has held it in 25 quarters since.
  • Jane Street's ImmunityBio position peaked at $31.6M in Q3 2025.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.